Tag Archives: Patients

Can UV Light Treat the Blood of COVID-19 Patients?

Is it possible that ultraviolet light (UV) might be an internal treatment for SARS-CoV-2? We know that it kills pathogens, especially on surfaces. And, it’s already used in food processing,1 wastewater treatment facilities2 and medical settings to kill germs3 — in fact, according to DukeHealth, it can cut the transmissibility of four major superbugs.4 William… Read More »

FDA Approves Darzalex Faspro (daratumumab and hyaluronidase-fihj) for the Treatment of Patients with Multiple Myeloma

FDA Approves Darzalex Faspro (daratumumab and hyaluronidase-fihj) for the Treatment of Patients with Multiple Myeloma Print this page HORSHAM, Pa., May 1, 2020 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approved Darzalex Faspro (daratumumab and hyaluronidase-fihj), a new subcutaneous formulation of daratumumab. Darzalex Faspro™ is approved in four regimens… Read More »

Which multivitamin is best for hiv patients

Planned statistical analysis For the primary outcomes, we will which intention-to-treat analyses for all primary outcomes. Eligible patients are HIV-positive adults aged wjich for 18 years, and are randomized to receive best a placebo; or multivitamins that include a single RDA of the following vitamins: 1. Low serum levels of micronutrients, commonly seen in malnourished… Read More »

Recovered South Korean virus patients test positive again

At least 179 recovered South Korean coronavirus patients have tested positive again for the dangerous bug, officials said. South Korea’s Centres for Disease Control and Prevention (KCDC) announced that the tally accounted for 16 new cases detected of patients relapsing from the killer virus, according to media reports. Patients in their 20s were responsible for… Read More »

Bristol Myers Squibb’s Opdivo-Yervoy combo helps mesothelioma patients live longer

Bristol-Myers Squibb’s Opdivo-Yervoy combo is awaiting some critical decisions in non-small cell lung cancer, but in the meantime, it’s making its mark in a smaller indication, too. The immuno-oncology duo topped chemo at extending the lives of phase 3 trial patients with previously untreated malignant pleural mesothelioma (MPM), the company said Monday. The rare cancer,… Read More »

FDA Approves Triferic AVNU (ferric pyrophosphate citrate), Intravenous Formulation of Triferic for Replacement of Iron and Maintenance of Hemoglobin in Hemodialysis Patients

Print this page WIXOM, Mich., March 27, 2020 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (NASDAQ:RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced that the U.S. Food and Drug Administration (“FDA”) has approved its New Drug Application (“NDA”) for its intravenous formulation of Triferic, Triferic AVNU.… Read More »